FACULTAD DE CIENCIAS BIOMÉDICAS Y DE LA SALUD
Facultad
Washington University in St. Louis School of Medicine
San Luis, Estados UnidosPublicaciones en colaboración con investigadores/as de Washington University in St. Louis School of Medicine (11)
2022
-
SLITRK2 variants associated with neurodevelopmental disorders impair excitatory synaptic function and cognition in mice
Nature Communications, Vol. 13, Núm. 1
-
Validation and utility of ARDS subphenotypes identified by machine-learning models using clinical data: an observational, multicohort, retrospective analysis
The Lancet Respiratory Medicine, Vol. 10, Núm. 4, pp. 367-377
2021
-
The efficacy and safety of enzalutamide with trastuzumab in patients with HER2+ and androgen receptor-positive metastatic or locally advanced breast cancer
Breast Cancer Research and Treatment, Vol. 187, Núm. 1, pp. 155-165
-
The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group
npj Breast Cancer, Vol. 7, Núm. 1
2020
-
Community Health Behaviors and Geographic Variation in Early-Onset Colorectal Cancer Survival Among Women
Clinical and translational gastroenterology, Vol. 11, Núm. 12, pp. e00266
-
Effect of platelet storage duration on clinical outcomes and incremental platelet change in critically ill children
Transfusion, Vol. 60, Núm. 12, pp. 2849-2858
-
Enhanced MAPK1 Function Causes a Neurodevelopmental Disorder within the RASopathy Clinical Spectrum
American Journal of Human Genetics, Vol. 107, Núm. 3, pp. 499-513
-
Epilepsy and Electroencephalographic Abnormalities in SATB2-Associated Syndrome
Pediatric Neurology, Vol. 112, pp. 94-100
2019
-
A Summary of the Fight Colorectal Cancer Working Meeting: Exploring Risk Factors and Etiology of Sporadic Early-Age Onset Colorectal Cancer
Gastroenterology, Vol. 157, Núm. 2, pp. 280-288
2017
-
Identification of axon growth promoters in the secretome of the deer antler velvet
Neuroscience, Vol. 340, pp. 333-344
2014
-
Safety and efficacy of neratinib in combination with capecitabine in patients with metastatic human epidermal growth factor receptor 2-positive breast cancer
Journal of Clinical Oncology, Vol. 32, Núm. 32, pp. 3626-3634